Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph B

Showing results (721-730 of 763) with videos related to

Pageof 77
Sort By:
JCI Insight|April 10, 2023
LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4Hiroshi Oue, Yu Yamazaki, Wenhui Qiao, et al.
ACS Omega|November 25, 2024
Characterization and Performance Enhancement of Bio-Based Polyurethane-Modified Cement Mortar Utilizing Polyglycerol Polyester PolyolRenzo Miguel R Hisona, Christine Joy M Omisol, Tomas Ralph B Tomon, et al.
Blood|February 26, 2015
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemiaSaradhi Mallampati, Xiaohong Leng, Haiqing Ma, et al.
Archives of Internal Medicine|November 25, 2010
Validation of an atrial fibrillation risk algorithm in whites and African AmericansRenate B Schnabel, Thor Aspelund, Guo Li, et al.
Circulation|July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeLeslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
Acta Neuropathologica Communications|June 2, 2018
Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicityAlexandra M Nicholson, Xiaolai Zhou, Ralph B Perkerson, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care PlansPamela W Duncan, Rica M Abbott, Scott Rushing, et al.
Brain Pathology (Zurich, Switzerland)|March 12, 2021
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficitsRosa Rademakers, Alexandra M Nicholson, Yingxue Ren, et al.
BMC Neurology|July 19, 2017
The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trialPamela W Duncan, Cheryl D Bushnell, Wayne D Rosamond, et al.
Blood|August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignanciesJoshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Pageof 77

Showing results (721-730 of 763) with videos related to

Sort By:
Pageof 77
JCI Insight|April 10, 2023
LRP1 in vascular mural cells modulates cerebrovascular integrity and function in the presence of APOE4Hiroshi Oue, Yu Yamazaki, Wenhui Qiao, et al.
ACS Omega|November 25, 2024
Characterization and Performance Enhancement of Bio-Based Polyurethane-Modified Cement Mortar Utilizing Polyglycerol Polyester PolyolRenzo Miguel R Hisona, Christine Joy M Omisol, Tomas Ralph B Tomon, et al.
Blood|February 26, 2015
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemiaSaradhi Mallampati, Xiaohong Leng, Haiqing Ma, et al.
Archives of Internal Medicine|November 25, 2010
Validation of an atrial fibrillation risk algorithm in whites and African AmericansRenate B Schnabel, Thor Aspelund, Guo Li, et al.
Circulation|July 13, 2016
Clinical Trial of the Protein Farnesylation Inhibitors Lonafarnib, Pravastatin, and Zoledronic Acid in Children With Hutchinson-Gilford Progeria SyndromeLeslie B Gordon, Monica E Kleinman, Joe Massaro, et al.
Acta Neuropathologica Communications|June 2, 2018
Loss of Tmem106b is unable to ameliorate frontotemporal dementia-like phenotypes in an AAV mouse model of C9ORF72-repeat induced toxicityAlexandra M Nicholson, Xiaolai Zhou, Ralph B Perkerson, et al.
Circulation. Cardiovascular Quality and Outcomes|October 26, 2018
COMPASS-CP: An Electronic Application to Capture Patient-Reported Outcomes to Develop Actionable Stroke and Transient Ischemic Attack Care PlansPamela W Duncan, Rica M Abbott, Scott Rushing, et al.
Brain Pathology (Zurich, Switzerland)|March 12, 2021
Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficitsRosa Rademakers, Alexandra M Nicholson, Yingxue Ren, et al.
BMC Neurology|July 19, 2017
The Comprehensive Post-Acute Stroke Services (COMPASS) study: design and methods for a cluster-randomized pragmatic trialPamela W Duncan, Cheryl D Bushnell, Wayne D Rosamond, et al.
Blood|August 9, 2013
Antagonistic activities of the immunomodulator and PP2A-activating drug FTY720 (Fingolimod, Gilenya) in Jak2-driven hematologic malignanciesJoshua J Oaks, Ramasamy Santhanam, Christopher J Walker, et al.
Pageof 77